ALLE vs NEUP · P/E 21, rev $2.19B vs rev $15.7M
Allegion PLC (ALLE) versus Neuphoria Therapeutics Inc (NEUP) — a side-by-side from cached financials, not a winner call.
Allegion PLC (ALLE) is a security & protection services company listed on US.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
ALLE currently screens at market cap $12.71B and trailing P/E 20.7. NEUP currently screens at market cap $23.6M.
Not investment advice. Open the ALLE and NEUP stock pages for the full models.
Not investment advice.